Study of the Oral Treatment MTR-601 in Cervical Dystonia

Summary

Study MTR-601-201 is an 8-week, randomized, placebo-controlled study to examine the safety, tolerability, and efficacy of MTR-601 in participants with cervical dystonia.

Timeline

Start

2025-02-28

Primary completion

2026-07-08

Completion

2026-08-03

Outcome

Outcome not reported

Stopped: “Pending further safety evaluation”

Drugs

Indications